InsiderTrades

Form 4 for GEHC GE HealthCare

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001628280-23-006430 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-03 2023-03-01+ GEHC Rott Roland CEO, Ultrasound F - Tax $75.20 -1,469 25.6K -5% -$110.5K
D 2023-03-03 2023-03-01 GEHC Rott Roland CEO, Ultrasound A - Grant $0.00 +4,150 27.1K +18% $0
D 2023-03-03 2023-03-01 GEHC Rott Roland CEO, Ultrasound A - Grant $0.00 +11.6K 11.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 per share 2023-03-01 F D 928 $75.30 26,186 D — — (F3) Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
2 Common Common Stock, par value $0.01 per share 2023-03-02 F D 541 $75.04 25,645 D — — (F3) Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
3 Common Common Stock, par value $0.01 per share 2023-03-01 A A 4,150 $0.00 27,114 D — — (F1) Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
4 Derivative Employee Stock Option (right to buy) 2023-03-01 A A 11,578 $0.00 11,578 D $75.30 · — to 2033-03-01 11,578 Common Stock, par value $0.01 per share (F4) Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.